Skip to main navigation

Skip to Content

Menu

About Cerevel
Our Programs
Our Science
Investor & Media
Careers
- Working at Cerevel Therapeutics
- Open positions
Contact Us

Presentations

Presentations

Corporate Presentations

Scientific Publications

Cerevel Therapeutics Corporate Presentation

Nov 10, 2021

3Q 2021 Financial Results & Business Update 4.5 MB

Cerevel Therapeutics R&D Day Presentation

Oct 07, 2021

Cerevel Therapeutics R&D Day Presentation 3.3 MB

Cerevel Therapeutics Corporate Presentation

Aug 11, 2021

2Q 2021 Financial Results & Business Update 4.5 MB

Cerevel Therapeutics Corporate Presentation

May 17, 2021

1Q 2021 Financial Results & Business Update 4 MB

$125M Non-Dilutive Financing for Tavapadon Presentation

Apr 13, 2021

$125M Non-Dilutive Financing for Tavapadon Presentation 1.1 MB

Virtual R&D Event: Darigabat, PDE4, KORA

Jan 28, 2021

View PDF 4.4 MB

Pagination

First page
Previous page
Page 1
Current page 2

Print

RSS Feeds

Email Alerts

Investor Contact

Search

Cerevel

About CerevelAbout Cerevel
Our ProgramsOur Programs
- Tavapadon
- CVL-871
- CVL-865
- CVL-231
- CVL-936
Our ScienceOur Science
- Our scientific strategy
- Our pipeline
Our ProgramsOur Programs
- Tavapadon
- CVL-871
- Darigabat
- CVL-231
- CVL-936
Investors & MediaInvestors & Media
- Overview
- News & Events
- Stock
- Financials
- Governance
- Resources
CareersCareers
- Working at Cerevel Therapeutics
- Open Positions
Contact Us

Facebook
Twitter
LinkedIn
YouTube

Cerevel

Terms of Use
Privacy Policy
FCOI
Early Access Program (EAP) Policy

© 2023 Cerevel Therapeutics

CEREVEL and the CEREVEL logo are trademarks of

Cerevel Therapeutics. All Rights Reserved.